Skip to main content
. 2022 Oct 21;11(10):2080. doi: 10.3390/antiox11102080

Figure 7.

Figure 7

αBC-P inhibits TGFβ2-induced hRPE cell migration. Representative images (a) and graphs (b) of wound width in RPE cells co-treated with TGFβ2 and αBC-P. hRPE cells were divided into following treatment groups: control, TGFβ2 (10 ng/mL) and/or αBC-P (25, 50 and 75 μg/mL) for 24 h. αBC-P (75 μg/mL) significantly inhibited TGFβ2-treated hRPE cell migration compared to TGFβ2-only treated hRPE cells. αBC-P: αB crystallin-chaperone peptide. Scale bar: 1 mm. Values are means ± SEM. * p < 0.05. n = 8.